Market capitalization | $93.76m |
Enterprise Value | $113.35m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 1.29 |
P/S ratio (TTM) P/S ratio | 1.06 |
P/B ratio (TTM) P/B ratio | 0.82 |
Revenue growth (TTM) Revenue growth | 40.40% |
Revenue (TTM) Revenue | $88.18m |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
8 Analysts have issued a OptimizeRx Corporation forecast:
8 Analysts have issued a OptimizeRx Corporation forecast:
Sep '24 |
+/-
%
|
||
Revenue | 88 88 |
40%
40%
|
|
Gross Profit | 51 51 |
44%
44%
|
|
EBITDA | -3.33 -3.33 |
77%
77%
|
EBIT (Operating Income) EBIT | -7.57 -7.57 |
54%
54%
|
Net Profit | -24 -24 |
76%
76%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
OptimizeRx Corp. engages in the provision of digital health messaging via electronic health records, which serves as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers EHR workflow solutions which include financial messaging, patient education, and brand messaging; and brand support. The company was founded by David A. Harrell on November 8, 1985 and is headquartered in Rochester, MI.
Head office | United States |
CEO | Will Febbo |
Employees | 136 |
Founded | 1985 |
Website | www.optimizerx.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.